MYM Nutraceuticals Inc. (CSE:MYM)(OTCBB: MYMMF) (“MYM” or “The Company”) is pleased to announce that the Company and their partner, Elite Ventures, have acquired 1.6 million seeds with CBD levels of 10%-20% from the recently built, state-of-the-art, 57,600 square foot nursery owned by CROP in Nye County, Nevada.

MYM Nutraceuticals Inc. (CSE:MYM)(OTCBB: MYMMF) (“MYM” or “The Company”) is pleased to announce that the Company and their partner, Elite Ventures, have acquired 1.6 million seeds with CBD levels of 10%-20% from the recently built, state-of-the-art, 57,600 square foot nursery owned by CROP in Nye County, Nevada.

The newly built nursery is equipped with trays and LED lighting specially designed to enhance the growth of plant starts for the 2019 CBD farms licenced on CROP’s various properties in the state. This was a key project in order to maximize yield, reduce farming risk and costs for the 2019 planting season.

The global medical cannabis market value is expected to reach a value of US$ 45.4 Billion by 2024, with a CAGR of 22.9% during 2019-2024, according to IMARC research. The firm’s estimate for last year was that it would to reach US$ 13.4 Billion.

“With 1.6 million seeds purchased and being prepared to be planted, our 2019 grow season is nearly underway,” said Howard Steinberg, CEO of MYM. “The Nevada project is a key component in our strategy to create a massive CBD-rich hemp footprint around the globe with the goal of becoming one of the largest cultivators and bulk CBD isolate suppliers in the world.”

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on the global growth of Cannabis and hemp. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE BOARD

Howard Steinberg, CEO

MYM Nutraceuticals Inc.

www.mym.ca

Investor Relations

Billy Casselman

778-522-2261

investors@mym.ca

Keep up to date with MYM on our social media channels:

Twitter: @mymnutra

Facebook: @mymnutra

Instagram: @mymnutra

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

Click here to connect with MYM Nutraceuticals Inc. (CSE:MYM) for an Investor Presentation.